Vagus nerve stimulator market is expected to grow at a CAGR of 3.8% during the forecast period. Vagus nerve stimulator are those devices that are utilized to stimulate the vagus nerve with electrical impulses. It is used to treat epilepsy and depression. In vagus nerve stimulation, the stimulator is surgically implanted under the skin on the chest, and the device is connected to the left vagus nerve through a wire under the skin. When activated, the device sends the electrical signal to the certain areas of the brain along with the left vagus nerve to the brainstem. With the technological advancement, non-invasive vagus nerve stimulation devices are introduced by the companies which then receive approval by the FDA and CE marks for commercialization and marketing. The market is expected to grow in the near future during the forecast period. Whereas, North America and Europe are expected to be the major regions generating revenue for the market.

Request a Free Sample of our Report on Global Vagus Nerve Stimulators Market https://www.omrglobal.com/request-sample/vagus-nerve-stimulators-market

The incidence and prevalence rate of epilepsy is rising significantly across the globe. As per the Epilepsy Foundation, one in 26 people develops epilepsy at some point in their lifetime. As per the Institute for Health Metrics and Evaluation the prevalence of epilepsy has reached to more than 27.3 million in 2017 from about 25.3 million in 2013.

A full Report of France Cardiac Biomarker Market is Available at: https://www.omrglobal.com/industry-reports/vagus-nerve-stimulators-market

No significant US FDA approval for the Vagus Nerve Stimulator has been recorded in 2019. In October 2018, Electrocore has received the US FDA approval for its non-invasive vagus nerve stimulator therapy device to prevent cluster headache as well. It is a self-administered therapy using the GammaCore device. To use the device, the patient had to apply a conductive gel on the side of the neck and then given a mild electrical stimulation through the skin. In October 2017, the US FDA Approved Vagus Nerve Stimulation Therapy system which has an implantable generator (SenTivaTM) and the Therapy Programming System for the treatment of epilepsy.

Global Vagus Nerve Stimulators Market Segmentation

By Product

• Implantable
• External

By Applications

• Epilepsy
• Depression
• Others (Migraine)

By End-Users

• Hospitals and Clinics
• Research Institutes

Regional Analysis

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

Company Profiles

• Aleva Neurotherapeutics SA
• BioControl Medical
• Bioness Inc.
• Boston Scientific Corp.
• ElectroCore LLC
• EnteroMedics Inc.
• LivaNova Plc.
• Medtronic Plc
• NeuroPace Inc.
• Nevro Corp.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/vagus-nerve-stimulators-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404